Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 14/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL75348 | 0.90 | CYP1B1 (0.51) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL21888318 | 0.88 | CYP1B1 (0.47) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL22727693 | 0.86 | MAPT (0.40) | CYP1A2ALDH1A1POLBCYP2A6TYMS | |
| SCHEMBL14680419 | 0.85 | CYP1B1 (0.49) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL21888684 | 0.84 | CYP1B1 (0.46) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL21888320 | 0.82 | CYP1B1 (0.47) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL14680338 | 0.76 | CYP1B1 (0.49) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL15028262 | 0.75 | MAPT (0.47) | CYP1A2ALDH1A1KDM4EMEN1NPC1 | |
| SCHEMBL14680520 | 0.74 | CYP1B1 (0.43) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 | |
| SCHEMBL15457926 | 0.73 | CYP1A2 (0.58) | CYP1B1CYP1A2ALDH1A1POLBRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200377433-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377433-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNL2, MCM4, CCNT1 | CYP1B1 464/4885CYP1A2 239/4885ALDH1A1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.